Why the study?
Does intravenous protamine sulfate alter hemodynamics in patients after cardiopulmonary bypass?
Does intravenous protamine sulfate alter hemodynamics in patients after cardiopulmonary bypass?
Protamine administration after cardiopulmonary bypass causes significant hypotension in patients with poor left ventricular function, warranting cautious administration in this subgroup.
Answers are grounded in this paper and cite their sources.
Protamine-associated hypotension in poor LV function may warrant caution; leaves open whether randomized data confirm differential effects by ventricular function.
Hemodynamic responses to intravenous protamine sulfate in 40 patients were evaluated. The dose of protamine administered was calculated as adequate to reverse residual heparin as measured by the activated clotting time (ACT). Thirty patients (n = 30) received protamine at a rate of 0.5 mg/kg/min and the remainder (n = 10) received protamine at a rate of 1 mg/kg/min. Hemodynamic measurements were made before protamine, at 5-min intervals during administration, and 5 min after completion of the infusion. No statistically significant changes in cardiac output, systemic arterial blood pressure, or vascular resistance were seen when protamine was administered to patients with good left ventricular function after cardiopulmonary bypass. However, in patients with poor left ventricular function after cardiopulmonary bypass, protamine infusion was associated with systemic vasodilation that was only partially compensated for by an increase in cardiac index, resulting in a 12% decrease in mean blood pressure (P less than 0.05). Thus protamine should be administered cautiously to patients who have poor left ventricular function after cardiopulmonary bypass.
No takes yet. Share an insight, caveat, or question.
Michaels et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: